Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NUWE - Nuwellis, Inc.


IEX Last Trade
1.02
-0.360   -35.294%

Share volume: 0
Last Updated: Tue 24 Dec 2024 05:59:36 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$1.38
-0.36
-26.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
8.50%
1 Month
-7.26%
3 Months
-17.18%
6 Months
-85.76%
1 Year
-94.76%
2 Year
-99.59%
Key data
Stock price
$1.02
P/E Ratio 
0.00
DAY RANGE
$1.02 - $1.38
EPS 
$0.00
52 WEEK RANGE
$1.07 - $30.10
52 WEEK CHANGE
-$94.79
MARKET CAP 
2.651 M
YIELD 
N/A
SHARES OUTSTANDING 
1.867 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$454,021
AVERAGE 30 VOLUME 
$380,430
Company detail
CEO: Nestor Jaramillo
Region: US
Website: nuwellis.com
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Nuwellis, Inc. focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States.

Recent news